Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celltex AdMSCs in rheumatoid arthritis
NCT04170426Phase 2Not yet recruiting
- Sponsor
- Celltex Therapeutics
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of Celltex AdMSCs in rheumatoid arthritis (RA), sponsored by Celltex Therapeutics. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
Celltex AdMSCs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04170426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04170426.